《滬深兩市》 A股三大指數微微低開 比亞迪低開4.6% 康希諾生物漲11.5%
內地昨日(4日)新增本土確診病例303例,新增本土無症狀感染者1,249例。人行今日(5日)開展20億元人民幣(下同)7天期逆回購操作,單日零投放零回籠,利率持平於2%。人民幣兌美元中間價今下調81點,再創兩年低。A股三大指數低開。
上證綜指微微低開2點,報3,183點;深証成指低開35點或0.3%,報11,667點;創業板指低開4點或0.2%,報2,528點。
中資金融股工行(601398.SH)及建行(601939.SH)平開。
股神巴菲特繼續減持比亞迪股份,8月新能源汽車銷量17.5萬輛,按年增長184.84%,比亞迪(002594.SZ)股價低開4.6%。天齊鋰業(002466.SZ)及贛鋒鋰業(002460.SZ)均低開1.2%。寧德時代(300750.SZ)低開0.9%。
麗珠醫藥(000513.SZ)重組新型冠狀病毒融合蛋白疫苗被納入序貫加強免疫緊急使用,股價高開3.3%。
康希諾生物(688185.SH)公布,公司吸入用重組新型冠狀病毒疫苗作為加強針被納入緊急使用,股價高開11.5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.